Albendazole Treatment of Children with Ascariasis Enhances the Vibriocidal Antibody Response to the Live Attenuated Oral Cholera Vaccine CVD 103-HgR

作者: Philip J. Cooper , Martha E. Chico , Genevieve Losonsky , Carlos Sandoval , Ivan Espinel

DOI: 10.1086/315837

关键词:

摘要: Because concurrent infections with geohelminth parasites might impair the immune response to oral vaccines, we studied vibriocidal antibody cholera vaccine CVD 103-HgR in children infected Ascaris lumbricoides and investigated effect of albendazole pretreatment on postvaccination response. Children ascariasis were randomized receive either 2 sequential doses 400 mg or placebo. After second dose, was given, serum levels measured before 10 days after vaccination. Postvaccination rates seroconversion greater treatment group that received ( ). Significantly seroconP p .06 version geometric mean titer observed subjects non-O ABO blood groups. A significant association between group, suggesting A. vaccine, particularly Helminth are estimated infect 3 billion humans worldwide most prevalent poorer regions developing world. Most these due intestinal helminths (or geohelminths), infection which has been associated childhood morbidity, including stunted growth [1], poor cognitive performance [2], malabsorption [1, 3]. Malabsorption resulting macronutrient micronutrient deficiencies is closely those geohelminths inhabit small intestines, namely 4], hookworm [5], Strongyloides stercoralis [6]. We have postulated presence bowel not only affect absorption nutrients but also may interfere attachment vaccines M cells overlie gut-associated lymphoid tissue at mucosal surface.

参考文章(52)
Myron M. Levine, Nathaniel F. Pierce, Immunity and Vaccine Development Cholera. pp. 285- 327 ,(1992) , 10.1007/978-1-4757-9688-9_14
Anisa Saad, W. H. Mosley, A. S. Benenson, Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique. Bulletin of The World Health Organization. ,vol. 38, pp. 277- 285 ,(1968)
Z. S. Pawlowski, D. W. T. Crompton, M. C. Nesheim, Ascariasis and human nutrition. Ascariasis and its prevention and control.. pp. 87- 100 ,(1989)
ZS Pawlowski, A Davis, DWT Crompton, MC Nesheim, Ascariasis and its prevention and control. Taylor & Francis Ltd. ,(1989)
N. Bellesi, A. C. Linhares, J. D. P. Mascarenhas, S. A. Valente, F. L. P. Ramos, T. A. F. Monteiro, C. S. Oliveira, Zea Lins-Lainson, Y. B. Gabbay, R. B. de Freitas, Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine in Belém, Brazil. Bulletin of The World Health Organization. ,vol. 74, pp. 491- 500 ,(1996)
S J Cryz, M M Levine, G Losonsky, J B Kaper, B Althaus, Safety and immunogenicity of a booster dose of Vibrio cholerae CVD 103-HgR live oral cholera vaccine in Swiss adults. Infection and Immunity. ,vol. 60, pp. 3916- 3917 ,(1992) , 10.1128/IAI.60.9.3916-3917.1992
Kshetrabasi Tripathy, Edgar Duque, Oscar Bolaños, Hernan Lotero, Luis Guillermo Mayoral, Malabsorption syndrome in ascariasis The American Journal of Clinical Nutrition. ,vol. 25, pp. 1276- 1281 ,(1972) , 10.1093/AJCN/25.11.1276
E Gotuzzo, B Butron, C Seas, M Penny, R Ruiz, G Losonsky, C F Lanata, S S Wasserman, E Salazar, J B Kaper, Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels. Infection and Immunity. ,vol. 61, pp. 3994- 3997 ,(1993) , 10.1128/IAI.61.9.3994-3997.1993